Research: LOPEZ-SAEZ and co-workers,

Listed in Issue 91

Abstract

LOPEZ-SAEZ and co-workers, Department of Medicien, University of Cadiz School of Medicine, c/Dr. Maranon 6, E-11002 Cadiz, Spain, juanbosco.lopez@uca.es, have studied selenium and breast cancer.

Background

Controversy surrounds the relationship between low serum levels of selenium and reduced activity of selenium-dependent enzymes (such as glutathione peroxidase) and an increased risk of breast cancer.

Methodology

In this case-control study, the serum concentrations of selenium were compared in 200 women with breast cancer, 100 healthy women, and 100 women with chronic diseases.

Results

Mean serum concentrations of selenium in women with breast cancer were 81.1 micrograms/litre, and in women with other diseases they were 98.5 micrograms/litre (p = 0.0001).

Conclusion

Alterations in selenium concentrations in women with breast cancer appear to be a consequence of the disease rather than a cause. Very low selenium status could be due to the nature of cancer.

References

Lopez-Saez JB, Senra-Varela A, Pousa-Estavez L. Selenium in breast cancer. Oncology 64 (3): 227-231, 2003.

ICAN 2024 Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

top of the page